Position in OGN
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$30,900,456
+$17,532,212 QoQ
Shares Held
2,282,161
+2.3% QoQ
Ownership
0.869%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#23
of 626 holders
Holding Since
Jun 2021
21 quarters on record
Voting authority
Sole 94%
Shared 0%
None 6%
Common Shares in OGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Bank of New York Mellon Corp holds $24,361,895,957 across 16 Drug Manufacturers - General names. OGN ranks #13 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
4,783,459 | $5,737,424,695 | |
| 2 | JNJ |
Johnson & Johnson
|
21,683,347 | $5,506,919,623 | |
| 3 | ABBV |
AbbVie Inc.
|
12,853,368 | $3,234,421,512 | |
| 4 | MRK |
Merck & Co., Inc.
|
18,340,173 | $2,356,712,224 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
15,263,929 | $1,928,444,775 | |
| 6 | PFE |
Pfizer Inc
|
57,879,546 | $1,393,739,453 | |
| 7 | AMGN |
Amgen Inc
|
3,695,586 | $1,338,245,590 | |
| 8 | AZN |
Astrazeneca PLC
|
6,753,962 | $1,280,686,266 |
All Filings in OGN
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $30,900,456 | 2,282,161 | Shares | Defined | 2026-08-06 | |
| 2026-03-31 | $13,368,244 | 2,231,761 | Shares | Defined | 2026-05-05 | |
| 2025-12-31 | $16,210,826 | 2,260,925 | Shares | Defined | 2026-02-10 | |
| 2025-09-30 | $38,148,473 | 3,571,955 | Shares | Other | 2025-11-03 | |
| 2025-06-30 | $34,651,140 | 3,579,664 | Shares | Other | 2025-08-05 | |
| 2025-03-31 | $54,863,793 | 3,684,607 | Shares | Defined | 2025-04-29 | |
| 2024-12-31 | $56,735,757 | 3,802,665 | Shares | Defined | 2025-02-04 | |
| 2024-09-30 | $75,596,896 | 3,951,746 | Shares | Other | 2024-11-12 | |
| 2024-06-30 | $82,271,501 | 3,974,469 | Shares | Other | 2024-07-25 | |
| 2024-03-31 | $75,132,484 | 3,996,409 | Shares | Other | 2024-04-25 | |
| 2023-12-31 | $59,473,754 | 4,124,394 | Shares | Other | 2024-01-29 | |
| 2023-09-30 | $50,616,179 | 2,915,679 | Shares | Other | 2023-10-24 | |
| 2023-06-30 | $62,321,177 | 2,994,771 | Shares | Other | 2023-08-03 | |
| 2023-03-31 | $128,109,576 | 5,446,836 | Shares | Defined | 2023-05-09 | |
| 2022-12-31 | $153,455,565 | 5,494,292 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $212,151,503 | 9,066,304 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $277,827,020 | 8,231,912 | Shares | Other | 2022-08-15 | |
| 2022-03-31 | $294,458,353 | 8,429,956 | Shares | Defined | 2022-05-11 | |
| 2021-12-31 | $253,651,536 | 8,330,100 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $173,747,216 | 5,298,787 | Shares | Defined | 2021-11-18 | |
| 2021-06-30 | $128,306,478 | 4,240,135 | Shares | Defined | 2021-08-11 | |
| No filing history on record for this holder in this stock. | ||||||